Hait William's Form 4 filing
Johnson & Johnson (JNJ) · filed Apr 25, 2022
- Accession no.
- 0001225208-22-006073
- Filed
- Apr 25, 2022
- Trade date
- Apr 21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.45M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hait WilliamCIK 0001904791 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2022 | Common Stock | MOption exerciseAcquired | +29,699 | $90.44 | +$2,685,977.56 | 109,935 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −100 | $183.58F1 | −$18,358 | 109,835 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −100 | $183.58F1 | −$18,358 | 109,735 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −225 | $183.58F1 | −$41,305.5 | 109,510 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −700 | $183.58F1 | −$128,506 | 108,810 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −1,403 | $183.58F1 | −$257,562.74 | 107,407 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −1,696 | $183.58F1 | −$311,351.68 | 105,711 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −2,884 | $183.58F1 | −$529,444.72 | 102,827 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −22,591 | $183.58F1 | −$4,147,255.78 | 80,236 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2022 | Common Stock | MOption exerciseDisposed | −29,699 | $0.00 | $0 | 29,698 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from 183.57 to 183.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 8 transactions in Table I.
Remarks
Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer